Literature DB >> 31060933

Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.

Patrick M Wieruszewski1, Misty A Radosevich2, Kianoush B Kashani3, Richard C Daly4, Erica D Wittwer5.   

Abstract

Entities:  

Keywords:  angiotensin II; cardiac surgery; cardiopulmonary bypass; case report; shock; vasoplegia

Mesh：

Substances：

Year:  2019        PMID： 31060933     DOI： 10.1053/j.jvca.2019.03.004

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  8 in total

1.  Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia.

Authors:  Albert D Bui; Scott A Helgeson; Pramod K Guru; Devang K Sanghavi
Journal:  BMJ Case Rep       Date:  2020-06-28

Review 2.  Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies.

Authors:  Theresa J Barnes; Maxwell A Hockstein; Craig S Jabaley
Journal:  SAGE Open Med       Date:  2020-06-25

3.  Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study.

Authors:  Othmar Kofler; Maximilian Simbeck; Roland Tomasi; Ludwig Christian Hinske; Laura Valentina Klotz; Florian Uhle; Frank Born; Maximilian Pichlmaier; Christian Hagl; Markus Alexander Weigand; Bernhard Zwißler; Vera von Dossow
Journal:  J Clin Med       Date:  2022-02-20       Impact factor: 4.241

Review 4.  The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.

Authors:  Olga Papazisi; Meindert Palmen; A H Jan Danser
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-21       Impact factor: 3.947

5.  Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia.

Authors:  Caitlin C Ten Lohuis; Sarah C Burke; Cooper J Jannuzzo; Nicholas A Barker; Edward P Chen; Laurence W Busse
Journal:  Crit Care Explor       Date:  2022-05-13

6.  Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series.

Authors:  Samuel B Konkol; Matthew J Morrisette; Matthew C Hulse; Kyle B Enfield; Andrew D Mihalek
Journal:  Ann Card Anaesth       Date:  2022 Jul-Sep

7.  A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery.

Authors:  T G Coulson; L F Miles; A Serpa Neto; D Pilcher; L Weinberg; G Landoni; A Zarbock; R Bellomo
Journal:  Anaesthesia       Date:  2022-09       Impact factor: 12.893

8.  Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.

Authors:  Patrick M Wieruszewski; Erica D Wittwer; Kianoush B Kashani; Daniel R Brown; Simona O Butler; Angela M Clark; Craig J Cooper; Danielle L Davison; Ognjen Gajic; Kyle J Gunnerson; Rachel Tendler; Kristin C Mara; Erin F Barreto
Journal:  Chest       Date:  2020-08-31       Impact factor: 9.410
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.